Ekso Bionics Statistics
Share Statistics
Ekso Bionics has 29.02M
shares outstanding. The number of shares has increased by 37.16%
in one year.
| Shares Outstanding | 29.02M |
| Shares Change (YoY) | 37.16% |
| Shares Change (QoQ) | 12.85% |
| Owned by Institutions (%) | 19.9% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 471 |
| FTD / Avg. Volume | 0.25% |
Short Selling Information
The latest short interest is 436.26K, so 1.76% of the outstanding
shares have been sold short.
| Short Interest | 436.26K |
| Short % of Shares Out | 1.76% |
| Short % of Float | 1.79% |
| Short Ratio (days to cover) | 3.59 |
Valuation Ratios
The PE ratio is -1.09 and the forward
PE ratio is -4.38.
Ekso Bionics's PEG ratio is
0.02.
| PE Ratio | -1.09 |
| Forward PE | -4.38 |
| PS Ratio | 0.69 |
| Forward PS | 0.2 |
| PB Ratio | 0.97 |
| P/FCF Ratio | -1.24 |
| PEG Ratio | 0.02 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Ekso Bionics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.5,
with a Debt / Equity ratio of 0.47.
| Current Ratio | 2.5 |
| Quick Ratio | 1.89 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | -0.63 |
| Debt / FCF | -0.61 |
| Interest Coverage | -38.88 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $293,852.46 |
| Profits Per Employee | $-185,737.7 |
| Employee Count | 61 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 1.84 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -67.46% in the
last 52 weeks. The beta is 1.09, so Ekso Bionics's
price volatility has been higher than the market average.
| Beta | 1.09 |
| 52-Week Price Change | -67.46% |
| 50-Day Moving Average | 0.43 |
| 200-Day Moving Average | 0.76 |
| Relative Strength Index (RSI) | 43.94 |
| Average Volume (20 Days) | 186,391 |
Income Statement
In the last 12 months, Ekso Bionics had revenue of 17.93M
and earned -11.33M
in profits. Earnings per share was -0.56.
| Revenue | 17.93M |
| Gross Profit | 9.51M |
| Operating Income | -10.46M |
| Net Income | -11.33M |
| EBITDA | -9.45M |
| EBIT | -11.06M |
| Earnings Per Share (EPS) | -0.56 |
Full Income StatementBalance Sheet
The company has 6.49M in cash and 5.98M in
debt, giving a net cash position of 510K.
| Cash & Cash Equivalents | 6.49M |
| Total Debt | 5.98M |
| Net Cash | 510K |
| Retained Earnings | -250.47M |
| Total Assets | 26.65M |
| Working Capital | 11.31M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -9.85M
and capital expenditures 0, giving a free cash flow of -9.88M.
| Operating Cash Flow | -9.85M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.88M |
| FCF Per Share | -0.49 |
Full Cash Flow StatementMargins
Gross margin is 53.06%, with operating and profit margins of -58.35% and -63.21%.
| Gross Margin | 53.06% |
| Operating Margin | -58.35% |
| Pretax Margin | -63.21% |
| Profit Margin | -63.21% |
| EBITDA Margin | -52.74% |
| EBIT Margin | -58.35% |
| FCF Margin | -55.14% |
